Home/ Stocks/ INBX

Inhibrx Biosciences, Inc. Common Stock

INBX XNAS

$84.52 +2.13 (+2.65%) ▲ 15-min delayed

Open

$80.68

High

$85.58

Low

$79.47

Volume

220.2K

Market Cap

$1.24B

About Inhibrx Biosciences, Inc. Common Stock

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 110 Website →

Related Market News

No specific coverage for INBX yet. Check out our latest market news or earnings calendar.

Get INBX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Inhibrx Biosciences, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.